Health-tech company Ezra has launched its AI-powered full-body MRI cancer screening service in the UK, starting in London through a partnership with Alliance Medical. A national rollout is planned for 2025.
Early Detection, Powered by AI
- Ezra’s platform reduces MRI scan times and enhances diagnostic efficiency.
- The 60-minute, non-invasive scan covers 13 organs, including the brain, liver, kidneys, and prostate.
- A proprietary E-SCORE system helps clinicians prioritise findings for follow-up.
Addressing a Rising Need
- Cancer diagnoses in UK adults aged 40–59 have risen 24% since 1995.
- Nearly 50% of UK cancers are still diagnosed at late stages.
Ezra’s UK debut marks a step toward proactive cancer screening for high-risk individuals—using AI to detect early and act early.
Follow MEDWIRE.AI for AI diagnostics and imaging insights.
